Together, these data demonstrate that combining DNA-PK inhibitors with Top2 poisons is an effective treatment approach that is able to kill non-proliferating, quiescent tumor cells that are otherwise resistant to Top2 poison treatments to result in greater anti-cancer effects. This evidence concerns the gene PRKDC and cancer.